Trinean is an IMEC/UGhent spin-off that provides small volume and high throughput solutions for measurement applications in the life science industry. The company commercializes the first µL micro-plate reader for bio-molecule quantification (DNA, RNA…) with an extension to other future applications such as physico-chemical testing and enzyme assays.
Location: Belgium, East Flanders, Ghent
Employees: 11-50
Total raised: $3.6M
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | Capital-E | capital-e.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.04.2012 | - | $3.6M | - |
Mentions in press and media 3
| Date | Title | Description |
| 30.04.2012 | Trinean Secures €2.7M | Trinean NV, a Gentbrugge, Belgium-based instrumentation company, has secured €2.7m of growth financing. The round was led by the current investors Vesalius Biocapital, Capital-E, Baekeland II Fund and Fidimec. The company intends to use the... |
| 30.04.2012 | Trinean Raises $3.6M | GHENT, BELGIUM, Trinean announced that the company has secured 2.7 million euro ($3.6 million) of growth financing provided by its existing investors. >> Click here for more funding data on Trinean >> To export Trinean fundi... |
| - | EMQN integrates Trinean’s DropSense™ | EMQN integrates Trinean’s DropSense™ into its standards QC procedures and quality assessment schemes for Molecular Genetic Labs |